Guidance and advocacy related to drug pricing and tariffs.
2025 · 3rd Quarter (July 1 - Sep 30)
MERCK SHARP & DOHME LLC
Filed by BALLARD PARTNERS.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 16, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- BALLARD PARTNERS
- Client
- MERCK SHARP & DOHME LLC
- Filing UUID
- a1cb8935-709e-4e79-8e9c-1e82abc52fe3
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Guidance and advocacy related to drug pricing and tariffs.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.